Literature DB >> 18661402

Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation.

Michele Gottardi, Cristina Danesin, Fabio Canal, Angelo Paolo Dei Tos, Piero Maria Stefani, Elisabetta Calistri, Ugo Salvadori, Filippo Gherlinzoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18661402     DOI： 10.1080/10428190802233165

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  5 in total

Review 1.  New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies.

Authors:  Kieron Dunleavy; Richard L Piekarz; Jasmine Zain; John E Janik; Wyndham H Wilson; Owen A O'Connor; Susan E Bates
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

Review 2.  New molecular insights into peripheral T cell lymphomas.

Authors:  Stefano A Pileri; Pier Paolo Piccaluga
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

3.  Bortezomib-based treatment for relapsed and refractory angioimmunoblastic T-cell lymphoma: Case report and literature review.

Authors:  Shuyan Liu; Zhengang Yuan; Chunyang Zhang; Weijun Fu; Jian Hou
Journal:  Oncol Lett       Date:  2012-05-21       Impact factor: 2.967

Review 4.  Treatment of hematologic neoplasms with new immunomodulatory drugs (IMiDs).

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2008-11-19

5.  Chidamide plus prednisone, etoposide, and thalidomide for untreated angioimmunoblastic T-cell lymphoma in a Chinese population: A multicenter phase II trial.

Authors:  Yawen Wang; Mingzhi Zhang; Wei Song; Qingqing Cai; Liling Zhang; Xiuhua Sun; Liqun Zou; Huilai Zhang; Lili Wang; Hongwei Xue
Journal:  Am J Hematol       Date:  2022-03-11       Impact factor: 13.265
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.